Slaughter and May looks set to lose valued UK biotech client Oxford GlycoSciences (OGS) following the start of a high-profile £100m bidding war for the company.

Allen & Overy (A&O) will certainly scoop OGS if its client Celltech closes its £101m cash offer in its aggressive take-over bid for the company.